2005
DOI: 10.1530/eje.1.01824
|View full text |Cite
|
Sign up to set email alerts
|

Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs

Abstract: Introduction: Invasive GH-secreting pituitary adenomas are rarely cured by surgery and although long-term therapy with somatostatin analogs (SSAs) may be employed, hormonal control is achieved in only 60% of cases. The impact of tumor debulking on subsequent control of acromegaly with SSAs has not been studied previously. Methods: We studied retrospectively the response to SSA therapy in acromegalic patients before and after incomplete surgical tumor excision. A case review identified 24 acromegalic patients w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

7
80
1
2

Year Published

2008
2008
2016
2016

Publication Types

Select...
7
2
1

Relationship

3
7

Authors

Journals

citations
Cited by 156 publications
(90 citation statements)
references
References 17 publications
7
80
1
2
Order By: Relevance
“…First, a majority of five patients in longterm remission (more than 12 months) were previously operated by unsuccessful neurosurgery except one de novo patient (one showing the occurrence of hemorrhagical intratumoral area after 12 months of SSTa withdrawal). This observation is consistent with previous data demonstrating that about 75-80% removal of the tumor by neurosurgery (debulking) improves hormonal control of acromegaly by SSTa (28,29). Secondly, the patients in median term remission (24 weeks) showed IGF-I concentrations lower than those found in other patients also during SSTa treatment.…”
Section: Discussionsupporting
confidence: 92%
“…First, a majority of five patients in longterm remission (more than 12 months) were previously operated by unsuccessful neurosurgery except one de novo patient (one showing the occurrence of hemorrhagical intratumoral area after 12 months of SSTa withdrawal). This observation is consistent with previous data demonstrating that about 75-80% removal of the tumor by neurosurgery (debulking) improves hormonal control of acromegaly by SSTa (28,29). Secondly, the patients in median term remission (24 weeks) showed IGF-I concentrations lower than those found in other patients also during SSTa treatment.…”
Section: Discussionsupporting
confidence: 92%
“…An important finding of this study is the significant debulking effect of surgery, which could be documented in a subgroup of patients who received CAB before and after surgical treatment, and experienced during their postoperative follow-up a further significant reduction in PRL levels while reducing their weekly CAB dose by 50%. This finding extends the role of surgery in the endocrine control of secreting adenomas (37). At last follow-up, patients treated by combined surgical and pharmacological approaches achieved a rate of PRL normalization and/or complete tumor shrinkage of 33.0 and 36.8% respectively, with a minority showing disease progression (5.3%).…”
Section: Discussionsupporting
confidence: 68%
“…The control rate in T2 hypo-intense adenomas is, however, similar to that achieved in other 'real world' clinical treatment settings, in which less than 25% of patients achieve strict control with octreotide or lanreotide (Mercado et al 2007, Espinosa-de-los-Monteros et al 2015. For those T2-hypo-intense macroadenomas that appear difficult to fully resect with primary surgery, it may be that surgical debulking of such tumors would lead to a better hormonal control rate with postoperative SSA therapy (Petrossians et al 2005, Jallad et al 2007, Karavitaki et al 2008.…”
Section: Discussionsupporting
confidence: 65%